Bufexamac in the treatment of progressive polyarthritis. Double-blind test using phenylbutazone, too
Pavelka, K.; Vojtísek, O.; Brémová, A.; Hándlová, D.; Kanková, D.; Králová, M.
Casopis Lekaru Ceskych 111(22): 514-517
1972
ISSN/ISBN: 0008-7335 PMID: 5031749 Document Number: 55417
Document emailed within 1 workday
Related Documents
Katsambas, A.; Vareltzidis, A. 1973: Therapeutic action of a new non-steroid drug (bufexamac) in the treatment of inflammatory dermatologic diseases. Double-blind clinical study Bruxelles Medical 53(8): 463-468Münzenberg, K.J.; Zorn, B. 1973: Treatment of arthrotic irritations with "R-760" (Flazalone) in double blind experiment with phenylbutazone Therapie der Gegenwart 112(9): 1448-1459
López Sánchez, J.; Yañez Marchena, G. 1983: Meclofenamate sodium, phenylbutazone, and naproxen in the treatment of degenerative joint disease. Report of a placebo-controlled double-blind clinical comparison Arzneimittel-Forschung 33(4a): 653-656
Pavelka, K.; Vojtisek, O.; Bremová, A.; Kauková, D.; Hándlová, D. 1976: A new pyrazolidine derivative - benetazone spofa - in short- and medium-term treatment of rheumatoid arthritis. (Double-blind comparative study with phenylbutazone) International Journal of Clinical Pharmacology and Biopharmacy 14(1): 20-28
Van Hoek, J. 1970: Double-blind comparison between 4-allyloxy-3-chlorophenylacetic acid (alclofenac) and phenylbutazone in osteoarthritis Current Therapeutic Research 12(9): 551-555
Eveld, H. 1977: Drug treatment of meteorism. Results of a double blind test Medizinische Monatsschrift 31(9): 424-425
Pillen, D. 1974: New drug (Sensit) for the treatment of coronary disease in a double blind test Fortschritte der Medizin 92(16): 709-711
Heiter, A.; Tausch, G.; Eberl, R. 1980: Controlled double blind comparison of acemetacin to indomethacin in patients with chronic polyarthritis Arzneimittel-Forschung 30(8a): 1427-1433
Shiokawa, Y.; Horiuchi, T.; Honma, M.; Kageyama, T.; Okada, T. 1977: Clinical evaluation of D-penicillamine for the treatment of rheumatoid arthritis by a double blind test Ryumachi 17(2): 205-210
Vachtenheim, J.; Zeman, P. 1983: Piroxicam in the treatment of active progressive polyarthritis Vnitrni Lekarstvi 29(4): 396-400
Vojtisek, O.; Kanková, D.; Pavelka, K.; Hándlová, D. 1975: Comparison of the effects of niflumic acid and aloxiprin in patients with progressive chronic rheumatoid arthritis in a double blind trial Arzneimittel-Forschung 25(8): 1308-1311
Kunz, W.; Rau, R.; Böni, A. 1971: Initial experience with isophosphamide in the treatment of progressive-chronic polyarthritis Schweizerische Medizinische Wochenschrift 101(31): 1151-1154
Mantykow, J.E.; Lepera, L.; Slafer, H.; Conti, L.; Lo Russo, J. 1970: Double-blind test of C.39'089-Ba in angina pectoris Prensa Medica Argentina 57(24): 1209-1212
Ferrandiz Arjonilla, L. 1978: Clinical double blind test with flupamesone and halcinonide Revista Clinica Espanola 149(5): 495-497
Lens, F. 1974: A new benzodiazepine screened in a parallel double-blind test Acta Psychiatrica Belgica 74(3): 327-337
Rapisarda, V.; Bongiorno, G. 1982: Double blind test with mianserin versus chlorimipramine Advances in Biochemical Psychopharmacology 32: 141-149
Gabka, J. 1976: Analgesic effect of Neuro-Demoplas in a double-blind test Fortschritte der Medizin 94(22-23): 1246-1250
Weber, H. 1971: Clinical experiences with a new spasmoanalgesic agent in double-blind test Zeitschrift für Allgemeinmedizin 47(6): 299-300
Litarczek, G.; Cristea, I.; Făgărăşanu, R. 1972: Pancuronium and Alcuronium, two competitive relaxants (comparison with the double-blind test) Chirurgia 21(10): 935-940
Wu, J.J.; Shih, L.Y.; Hsu, H.C.; Chen, T.H. 1997: The double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee Zhonghua Yi Xue Za Zhi 59(2): 99-106